��������

Emily Lam, MPH, currently serves as a Clinical Data Manager at Translational Drug Development (TD2) since January 2022, where responsibilities include designing Clinical Report Forms (CRFs) and data validations. Previously, from October 2019 to January 2022, Emily worked at the Children's Oncology Group, progressing through various roles that involved creating Electronic Case Report Forms (eCRFs) and overseeing clinical data management for Phase II and III studies. Other professional experiences include roles as a Clinical Research Analyst at Amphastar Pharmaceuticals, a Research Associate Intern at NYC Health + Hospitals, and a Research Data Assistant Intern at Carlton Lab, among others. Emily holds a Master’s Degree in Epidemiology from New York University and a Bachelor’s Degree in Biology from California State University, Los Angeles.